Dear Investors:

I would like to introduce myself as the new President and CEO of Citation Growth Corp. Open
communication is very important to me and I am committed to ensuring that investors, employees and the
market are always aware of our activities, challenges and accomplishments.

Our Q3 2019 financial reports and MD&A (to December 31, 2019) were both posted to SEDAR last week;
however, since much has transpired already in early 2020, I thought you might appreciate a more up-to-date
recap of management activities since the beginning of the New Year.

With over 27 years experience running businesses (both public and private) and having turned companies
around before, my first goal was to travel to each CGRO facility/asset for a site tour and to meet with
everyone who works at Citation. Here are some achievements and findings from my first few weeks on the
job:

  • Hired a new CFO, Kevin Cornish, who is a highly educated executive with cannabis industry
    experience and a background in successful company turn-arounds;
  • Toured the Apex (North Las Vegas) facility and interviewed all staff on four occasions and the
    Pahrump ACC facility on two occasions;
  • Toured the Desert Hot Springs (Palm Springs) dispensary and parcels of land in California and
    interviewed staff;
  • Toured the Celista, British Columbia facility in Canada and met with the Canadian grow team;
  • Met with our staff in Kelowna, BC;
  • Toured the Lynden, Washington property;
  • Reached out to various shareholders and noteholders and replied to various calls and emails
    from the investor community;
  • Met with our Controller based in Vancouver and our investors in the Celista asset;
  • Completed an in-depth review of all A/R, A/P and supplier contracts with the goal being to
    minimize unnecessary cash outflow and maximize profitability;
  • Sourced and appointed a new member of our Board of Directors, who will be announced before
    the end of next week. We are excited to welcome a professional who brings over 20 years’
    experience in capital markets to Citation as well as more than five years of cannabis experience
    from his time at a leading investment dealer in the space and Canadian cannabis cultivator.

    Kevin and I are working on a complete re-build of our pro forma financials (literally built from the ground up)
    and will distribute an updated Investor Presentation prior to the AGM, which has been scheduled for 1:30pm
    on April 23rd at the Sheraton Eau Claire (Foxglove Room) in Calgary, Alberta. This deck will highlight our
    new strategy of concentrating on the free cash flow potential in Nevada and California, the expansion of
    our US assets (non-dilutive and centered around profitable growth), various operational efficiencies we
    have already put into place as well as the opportunity to complete construction at the Celista facility that
    will grant us our License to Cultivate by Health Canada.

    I have also primed discussions with Citation’s legal counsel in Nevada pertaining to a resolution of the
    dispute between Citation and ACC Enterprises. A draft settlement agreement has been circulated and the
    parties believe a settlement is achievable. I will provide further updates on this initiative as the process
    moves along.

    Here are some observations from each Citation asset/facility:

    North Las Vegas – Apex
  • The Apex North Las Vegas facility is world class, which was proven by being awarded a
    Cannabis Cup award for the Fiore Superglue strain in December;
  • We are actively growing and cultivating several high-end cannabis flower strains with established
    downstream retail dispensary relationships across Nevada;
  • We are also converting cannabis flower to extracts and concentrates and producing our own
    brand of vape pens and packaged concentrates (Fiore and Diamante brands).
  • Immediate expansion of the extraction lab at Apex represents a huge potential to increase
    revenue and profitability in a short timeframe. We are already approaching other cannabis
    growers in the state to offer a “toll processing” service to convert their flower into high-dollar
    extracts, distillates and concentrates.
  • With 7.2 acres of land at Apex, we have plenty of room to expand operations (up to 8-10x our
    current footprint);
  • We are highly focused on this asset and will look to expand here aggressively as the Nevada
    cannabis market is currently restricted to new players (a good thing) and Citation has proven that
    our products are garnering higher-than-average wholesale prices to the retail community;
  • Average yields for the Apex facility have been approximately 80 pounds per month with the
    potential to grow to 150 pounds/month once the facility is fully optimized;
  • the extraction lab has only begun to produce concentrates and extracts, but over the 5-week
    period from late September to early November, approximately $200,000 worth of wholesale
    products were produced running a single 8-hour shift (roughly 40% capacity); we will seek to add
    a second crossover shift to maximize the potential output of these high value concentrates,
    distillates and extracts;
  • We also have two cultivation licenses assigned to this property (PhenoFarm and Eco Nevada)
    and we are looking into the possibility of selling one license, understanding that the moratorium
    on transferring licenses in Nevada will end sometime in 2020.

    Desert Hot Springs – California
  • Our dispensary, Green Leaf Wellness, is fully operational with a good mix of products, including
    2.0 products such as beverages, edibles, vape pens, etc.;
  • Our rating on WeedMaps is 4.7/5 and the foot traffic is consistent;
  • There are five other dispensaries in the same vicinity so it’s encouraging to learn that we have a
    good reputation for service and supply;
  • We have two parcels of land in the area that we are actively applying for CUP extensions of 10
    years as there is a real possibility to develop these parcels into grow operations over time;
  • We have two parties interested in buying the dispensary and land, but we think it’s prudent to
    begin sending a rotation of management down south to “work the floor” over the next few months
    to determine if optimization and increased revenue and margin potential exists.

    Celista, British Columbia (Canada)
  • We met with the local grow team as well as the investor group and took a tour of the facility,
    which has halted construction;
  • The 40 acres of land and two buildings (each with 10,000 square feet of cultivation and
    production space) are in good shape and ready to resume construction;
  • We estimate that $1.5mm will be required to finish construction of Building One, which when
    completed will allow Citation to complete our License to Cultivate application to Health Canada;
  • Building Two will require approximately $4mm in funding to complete;
  • Once both buildings are complete, our expected yield and revenue potential will be approximately
    1,500 pounds per building per year and north of $8mm in annual revenue (conservative
    estimates);
  • In speaking with our local growers, we were impressed by their technical expertise and clearly
    superior growing methodologies and outputs. We appear to have a genetics library that is not
    only unique and proprietary in the Canadian landscape, but also accompanied by several
    decades of experience coming from the MMAR/MMPR and micro grow industry in BC. There is
    also a focus on highly effective medical products and since there is potential to export medical
    products to Europe (for more revenue per gram than in Canada) we feel that creating a brand
    strategy around medicinal cannabis will be a natural evolution – both domestically and
    internationally;
  • An extraction lab is planned for one of the first two buildings, but we also have several
    relationships with nearby production labs in BC, meaning a JV to produce extracts and
    concentrates is also likely for the region;
  • For the remaining footprint on the 40 acres in Celista, there are several options to consider for
    future growth, namely: a) constructing an additional eight 10,000 square foot buildings owned by
    Citation (a total of 100,000 square feet of indoor cultivation), b) deploying modular buildings to
    provide a “community gardens” opportunity for local micro and craft growers, and/or c) growing
    outdoors on the bare land given the suitable agricultural growing environment.
  • We will continue to monitor the landscape for cannabis in Canada as the market has obviously
    been depressed for close to a year now. Any go-forward plan will be supported by sound
    fundamentals and financials.

    Lynden, Washington
  • We toured the 13 acre site and inspected the 26,000 square foot building, which is set up to
    house a grow operation;
  • A local real estate agent believes he has a buyer for the land and buildings, which are currently
    zoned for agricultural use;
  • We have rented out Building D to a local truck repair business who provides service to the local
    agricultural community;
  • Given that our short-term focus is going to be in Nevada and California, I have recommended to
    the Board that we sell the Washington asset as soon as possible and divert the sale proceeds to
    working capital and growth in our two US operations.

    OVERALL State of the Nation

    The past few months have been turbulent and challenging for the entire cannabis industry in North America
    and Citation Growth has not been immune to the sell side pressure in the marketplace. That said, Kevin
    and I have completed a comprehensive review of all operating facilities and non-operating assets to
    determine that our asset base (including licenses, equipment, retail brands and proprietary growing
    techniques) is in good shape relative to the market. If we are successful in selling our Washington asset
    and one of the Nevada license packages, we would greatly improve our working capital as well as fund a
    good portion of the Apex expansion.

    Green Leaf Wellness continues to be revenue neutral and we believe our optimization efforts over the
    coming months will begin to generate positive cash flow by the summer. We are also planning to bring Apex
    back up to full operational standards, which will result in generating positive cash flow on a monthly basis
    in our Q2/Q3 time frame. We have existing investors in the Celista asset who have expressed interest in re-
    starting construction and we are actively talking to new investors on all three prime assets. A recent non-brokered
    private placement has provided some necessary working capital that will give us the runway the
    new Board and Management Team needs to take off. We have also discussed non-dilutive debt financing
    to provide growth capital for expansion for Nevada and California.

    Our new management team will continue to focus on making progress on a day-by-day basis. I have turned
    companies around before and I believe we can do so with Citation. Over the next few quarters, my goal is
    to revitalize the company that will boast of positive US cash flow, non-dilutive expansion opportunities in
    the US and Canada, medical export opportunities to Europe and other parts of the world, top-shelf brand
    awareness at the retail level in the US and a fundamentally sound business strategy led by a solid
    management team.

    Open communication is very important to me and I would be happy to take your questions and/or discuss
    the finer details of our new strategy with you at any time. Should you wish to ask any questions in advance
    of the AGM, we have scheduled a conference call for Tuesday, March 17 at 2pm Mountain Standard Time.
    You may also email any comments or questions to IR@citationgrowth.com and we will respond quickly.

    Sincerely,
    Erik Anderson
    President & CEO
    Citation Growth Corp

    You can dial in using the conference bridge (toll free in the US and Canada):
    +1.778.819.8331 and passcode 370150#

KELOWNA, BRITISH COLUMBIA – February 13, 2020 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a vertically integrated licensed cannabis operator, has marked a “new beginning” in its Nevada operations to coincide with recent Senior Management, Executive and Board changes. The addition of multiple advanced genetics to our established Cannabis Genetics Breeding Program (the “CGBP”) compliments our hybrid strain, Superglue, which was awarded the 1st place High Times Cannabis Cup winner eight weeks ago in Las Vegas. Citation expects to continue to build a superior genetics library of strains that will be enhanced by proprietary organic grow methodologies.

“I’m excited to begin working immediately on a number of key priorities that support our business strategy. Citation Growth has built a truly strong foundation for the future, including award-winning premium organic brands, industry-leading cultivation methodologies and a dedication to operational excellence,” stated newly appointed CEO Erik Anderson. “We have a tremendous opportunity to drive profitable growth and cash flow by expanding our market position across all market segments and with new strains and product forms – and this work is already underway in our Nevada operations. The company is currently looking at non-dilutive financing options to expand our Nevada operations to meet the ever growing demand.”

The Nevada adult recreational market – and specifically the Las Vegas market – demands high THC dominant varieties. Citation is extremely proud to be providing consumers with our clean, triple-certified organic products, which consistently yield test results between 23-32% THC. To fulfill the “entourage effect,” our Café Fiore genetics tested with a higher than average inclusion of the cannabigerol molecule, CBGa. Researchers are further exploring CBG to treat bacterial infections such as MRSA, glaucoma, neurodegenerative conditions and tumors.

CBG can cost upwards of approximately $10,000 per pound while the same amount of CBD is priced around approximately $1,800 per pound. “The breeding focus for our US and Canadian operations is the implementation of potent, effective cannabinoid profiles that are not only enhanced but intensified with our shared organic cultivation methodologies,” confirmed Anderson. “In advance of US federal legalization, we are solidifying our position in the market to provide full spectrum flower and distillates to connoisseur consumers and medical patients across North America.”

About Citation Growth Corp.

Citation Growth Corp. (CSE:CGRO) (OTCQX:CGOTF) is a publicly traded company that has been investing in the development of the medical and recreational cannabis space since 2014. Citation has expanded its operating portfolio over time to include cultivation, production and retail offerings in key North American legal jurisdictions such as Nevada, California, Washington and British Columbia. For more information, please visit www.citationgrowth.com.

For Further Information:

Erik Anderson, President and CEO
1-877-438-5448 Ext 1
eanderson@citationgrowth.com

Neither the CSE nor its Regulation Services Provider, nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.

Cannabis Industry Involvement:

The Company owns marijuana licenses in California and Nevada. Marijuana is legal in each state; however, marijuana remains illegal under United States federal law and the approach to enforcement of U.S. federal law against marijuana is subject to change. Shareholders and investors need to be aware that federal enforcement actions could adversely affect their investments and that the Company’s ability to support continuing U.S.-based operations and its access private and public capital could be materially adversely affected.

The Company’s business is conducted in a manner consistent with state law and is in compliance with applicable state licensing requirements in the U.S. The Company has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with U.S. federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the U.S.

Unlike in Canada which has Federal legislation uniformly governing the cultivation, distribution, sale and possession of cannabis under the Cannabis Act (Canada), readers are cautioned that in the U.S., cannabis is largely regulated at the state level. Notwithstanding the permissive regulatory environment of medical cannabis at some of the state level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S. and as such, cannabis-related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under the U.S. federal law, nor will it provide a defense to any U.S. federal proceeding, which may be brought against the Company. Any such proceedings brought against the Company may materially adversely affect its operations and financial performance in the U.S. market.

Forward-Looking Statements:

This news release contains forward-looking statements or information that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the future business strategy; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; changes in laws and regulations; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the demand for our products; anticipated costs and ability to achieve goals; the Company’s ability to complete any contemplated transactions; historical prices of cannabis; and that there will be no regulation or law that will prevent the Company from operating its businesses; the state of the economy in general and capital markets in particular; present and future business strategies; the environment in which the Company will operate in the future; the estimated size of the cannabis market; and other factors, many of which are beyond the control of the Company. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Given these risks, uncertainties and assumptions, the reader should not place undue reliance on these forward-looking statements.

Forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: management estimated future capital expenditure costs, revenue, and timeframes for operations; business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

The securities of the Company are considered highly speculative due to the nature of the Company’s businesses.

Important factors that could cause actual results to differ materially from the Company’s expectations include, consumer sentiment towards the Company’s products and cannabis generally; risks related to the Company’s ability to maintain its licenses issued by governments in good standing; uncertainty with respect to the Company’s ability to grow, store and sell cannabis; risks related to the costs required to meet the obligations related to regulatory compliance; risks related to the extensive control and regulations inherent in the industry in which the Company operates; risks related to governmental regulations, including those relating to taxes and other levies; risks related an early stage business and a business involving an agricultural product and a regulated consumer product; risks related to building brand awareness in a new industry and market; risks relating to restrictions on sales and marketing activities imposed by governments; risks inherent in the agricultural business; risks relating to energy costs; risks relating to product liability claims, regulatory action and litigation; risks relating to recall or return of products; and risks relating to insurance coverage; global economic climate; equipment and building failures; increase in operating costs; decrease in the price of cannabis; security threats; government regulations; loss of key employees and consultants; additional funding requirements; volatility in the securities of the Company; changes in laws; technology failures; failure to obtain permits and licenses; anticipated and unanticipated costs; competition; risks associated with the substantial obligations of being a public company; and failure of counterparties to perform their contractual obligations. This list is not exhaustive of the factors that may affect the forward-looking statements. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements.

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release. Neither the Company nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to the reader or any person resulting from the use of the information in this news release by the reader or its representatives or for omissions from the information in this news release.

KELOWNA, BRITISH COLUMBIA – February 11, 2020 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator, producer and retailer, today announced that Interim CEO, Rahim Mohamed, has departed the Company for personal reasons, including resigning his Board position. The Board of Directors has named Erik Anderson, a proven business operator and veteran turnaround expert, as President and Chief Executive Officer, effective immediately. Mr. Anderson will also join the Board of Directors.

“We’ve established Citation Growth as a premium cannabis cultivator and producer focused on the U.S. market in Nevada and the Canadian market based out of British Columbia with one retail dispensary operating in California. The Board has determined that for the next phase of the Company’s growth we can benefit from leadership with the skills and experience to generate growth and transform the organization into a premium vertically integrated cannabis player. We’re pleased to have Erik join us to serve as our CEO and to champion our efforts to drive long-term, profitable growth and shareholder value,” said Marcel LeBlanc, Citation Growth Chairman.

Mr. Anderson has more than 25 years of experience operating successful businesses and delivering proven operating and financial performance. His career has included founding and operating a management consulting firm, multiple executive leadership roles in the telecom industry, establishing and eventually divesting a wireless GPS solution provider for major corporations in the energy space, operating and optimizing an oilfield services company during a turnaround phase, and establishing business strategies that included raising funds for multiple early-stage cannabis companies entering public markets. His experience driving growth and efficiencies at these companies, along with his deep knowledge of the cannabis space, will enable the Company to accelerate momentum during this period of transformation.

“I’m a firm believer the U.S. is on a path towards federal adult recreational legalization for cannabis which can provide outstanding growth opportunities to Citation Growth. I am excited to join this organization which operates already in several adult rec markets in the U.S. and which clearly has the technical expertise and proprietary cultivation methods to become a dominant force in both medical and recreational cannabis markets in the U.S. and Canada.”

About Citation Growth Corp.

Citation Growth Corp. (CSE:CGRO) (OTCQX:CGOTF) is a publicly traded company that has been investing in the development of the medical and recreational cannabis space since 2014. Citation has expanded its operating portfolio over time to include cultivation, production and retail offerings in key North American legal jurisdictions such as Nevada, California, Washington and British Columbia. For more information, please visit www.citationgrowth.com.

For Further Information:

Erik Anderson, President and CEO
1-877-438-5448 Ext 1
eanderson@citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

KELOWNA, BRITISH COLUMBIA – January 14, 2020 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces today that Howard Misle has resigned as Chief Executive Officer and a Board Member effective January 13, 2020. The Board of Directors has already begun interviewing prospective CEO candidates and expects to make an announcement shortly. In the interim, Mr. Rahim Mohamed will be the interim CEO.

The Company is also pleased to announce that it has appointed Mr. Kevin Cornish as its Chief Financial Officer effectively immediately.

Mr. Cornish has roots all over Eastern Canada, spending most of his life in Halifax Nova Scotia where he completed his education at Saint Mary’s University. He has worked in the service, hospitality, construction and cannabis industries over the course of his career. His expertise is focused in leadership, performance management, company growth and finance. He has experience sitting on the boards of both not for profit and for profit companies, volunteered with child development groups and is an advocate for mental health. Mr. Cornish has helped start up and mature companies grow in current and new markets. In 2018 he joined the cannabis industry due to having seen many people he knows positively affected by THC and CBD. Taking part in Canada’s history, Mr. Cornish was part of a Cannabis company that brought recreational Cannabis to Alberta and Canada. Mr. Cornish enjoys the many challenges that come with working in this industry leading up to legalization, post legalization and cannabis 2.0. With over 15 years of leadership experience in operations and finance, Mr. Cornish continues to grow along with this industry both personally and professionally.

Due to this change in management, the company has deemed it necessary to postpone its AGM scheduled for January 24, 2020 in Las Vegas Nevada to allow for an updated Management Information Circular to be filed and circulated to shareholders. Once a new date and location has been scheduled, management will issue out a News Release.

“We, the management and board, apologize for any inconvenience this may have caused any shareholders who may have already booked flights and hotels. We will be diligent and begin placing a new CEO as soon as possible” quoted Rahim Mohamed, President and Interim CEO.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

KELOWNA, BRITISH COLUMBIA – January 7th, 2020 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, is pleased to provide a corporate update.

US Focus in High Gear through Further Asset Rationalization

On December 23rd, 2019, Citation entered into an agreement to dispose of its Magna Bay asset for gross proceeds of $825,000. This asset disposition continues the strategy of Citation to further focus on its Nevada asset base where it is seeing stronger capital efficiency and return on invested capital.

The sale of the assets will bring in $600,000.00 in cash at closing and an additional $225,000.00 to be paid later in 2020.

After the closing on December 23rd, 2019, the proceeds from the transaction were deployed into Citation’s 100% owned and operation Pahrump, Nevada cultivation facility and the 100% owned and operated North Las Vegas “APEX” extraction facility located in North Las Vegas. Citation intends to continue to invest in its Nevada asset base and in 2020 will continue with its proposed expansion of its Pahrump facility. As previously announced, upon full build out, the Company’s Pahrump operations will have total output of 16,800 lbs / year across 50,000 sq ft of grow.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia and Las Vegas, Nevada– December 17th, 2019 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, is pleased to announce that its Fiore Cannabis – Super Glue strain has won 1 st Place at the High Times Cannabis Cup in Nevada for 2019 in the Hybrid Flower Category. This is the first Cannabis Cup win for Citation. This strain was developed in house by the genetics team at Citation at the APEX Campus in North Las Vegas and represents our Triple-Certified Organic family of flower. These further cements the organizational efficiencies and success that have come since the merger with the ACC Group of Companies.

Howard Misle, CEO of Citation commented “I am extremely proud and honoured to see our in house developed strain get a High Times Cannabis Cup in its first year of sales. This strain has seen immense success since going on shelves in 2019. As we continue to ramp up our Apex and Pahrump facilities, I expect to see continued top-tier strains emerge from our in-house genetics team”

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

KELOWNA, BRITISH COLUMBIA – December 5, 2019 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, is pleased to provide a corporate update.

Branded Product Production Ramp Up

Over the four weeks, Citation has fundamentally changed its revenue generation model through the startup of its production license. Over the last two months, the Company has begun to shift from a pure-play cultivation company to that of company focused on the high growth branded concentrates market through the introduction of its branded lines of waxes, shatters, infused pre-rolls and triple certified organic vapes.

Since this branded production ramp up, Citation has produced approximately USD$1.0 million worth of wholesale branded products. The Company is awaiting final state approval before sales of these products will commence. The company is expecting this approval at the beginning of next week.

Citation expects to further increase its sales and margins through the roll out of its Diamante and Superior branded concentrate lines that will complement the existing Fiore, Garden of Weeden and Blunt Box brands.

California Dispensary Optimization and Margin Growth

In Desert Hot Springs California, the Company’s 100% owned and operated retail dispensary, Green Leaf Wellness continues to see increased revenue and profit margins since its strategic assets rationalization program began in September.

In October, the dispensary had revenues of approximately USD$130,000 with a gross profit margin of 55%, compared to revenues of approximately USD$100,000 per month with profit margins of approximately 26% prior to the amalgamation of Citation and ACC Group of Companies.

As previously stated, through operational optimization and execution which should be finished by the end of 2019, the Company is expecting annualized revenue of greater than USD$2mm per year with gross profit margins of greater than 65%.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia – November 29, 2019 – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces that Ms. Nilda Rivera, the Company’s Chief Financial Officer, has tendered her resignation effective November 30, 2019. Ms. Rivera, who joined the Company in April 2019, will work with the Company on an orderly transition. The Company has commenced its search for a new CFO.

Rahim Mohamed, President and Director, commented, “On behalf of the Board, I would like to sincerely thank Ms. Rivera for her contributions to the Company and wish her the best in her future endeavours.”

The Board has appointed Rahim Mohamed, President, as Interim Chief Financial Officer while Citation completes its search for a permanent CFO.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia–(Newsfile Corp. – November 19, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces that the Company is now in production to have dispensary shelves stocked with the Company’s Proprietary organic products. Highly anticipated among dispensaries and enthusiasts, 25,000 live resin and distillate vape pens are set for distribution right ahead of the holiday rush.

“Our goal has been to retain the true essence of the plant and preserve that quality in a truly premium organic line, bringing to market a top-quality flavorful selection sure to compete well against the top contenders in its league.” stated, Rahim Mohamed, President. Products being prepared for launch are expected to hit shelves the last week of November.

These exclusive blends are sourced from exquisite sources like FIORE – TRIPLE CERTIFIED to produce specific products like Diamonds Live Resin, Sugar Wax and Live Resin Vape Pen formulations.

FIORE was born out of the necessity to bring exceptional cannabis genetics, growing standards and passion to commercial cannabis – keeping craft cannabis alive. Having passed through the ranks of the cannabis industry over the last 15 years, Management has taken the experience, the knowledge and the pride from growing exceptional cannabis and delivered it to the Nevada marketplace, enabling consumers with the opportunity to experience the simplicity, elegance and quality, in the finished product, that is decades in the making.

Diamante Labs was founded on the determination to formulate high quality extracts by using closed loop hydrocarbon processes. Based on research, management believes that up to 100% of products produced will be sold almost immediately upon delivery to dispensaries.

Vape Pen wholesale prices for Citations premium products are as follows:

Diamante Labs Live Resin Disposable Vape Pen, 0.30 grams per pen $22.00

Diamante Labs Live Resin cartridge, 0.50 grams $35.00 each

Superior Extracts distillate Disposable Vape Pen, 0.30 grams $13.00 per pen

Superior Extracts distillate cartridge, 0.50 grams $22.00 each

Superior Brand will be mostly Distillate to start and Diamante Labs Vape Pen will be mostly Live Resin to start. Citation will begin to diversify its product lines in the upcoming months to offer our customers a wide range of premium quality extracts. Our focus will be on our Triple-Certified Organic Diamante Labs products that are healthier for the end user.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
1-877-438-5448 Extension 718
RM@citationgrowth.com

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

http://citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Amendments to Celista Joint Venture Agreement Facilitate $6.3 Million in Capital to Conclude Construction of 10,000 Square Foot Celista Property

Kelowna, British Columbia–(Newsfile Corp. – November 12, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, announces that it has entered into an amended agreement (the “Amended Agreement”) with 1186626 B.C. Ltd. (“1186626 “) in connection with its joint venture agreement (the “JV Agreement”) on the Company’s Celista property located in British Columbia (the “Celista Project”).

Management has been resolute in their discovery of non-dilutive financing opportunities, in their commitment to maintain the integrity of the capital stricture. “We are very pleased with how this partnership has evolved. We have a big vision for this project, and are ready to move forward, full speed ahead, having the funding set in place.” Stated, Rahim Mohamed, President. The Company is currently in the process of constructing the first two of ten buildings, totaling 100,000 square feet of cultivation and processing space at this project.

Pursuant to the JV Agreement, 1186626 was to provide a capital contribution in the aggregate amount of $10 million (the “Capital Contribution”) to be delivered to the Company in four tranches of $2.5 million for the construction of ten 10,000 square foot cannabis production facilities. From the date of the agreement until the third year that all ten facilities are fully operational and in full production, project distributable cash flow (the “Project Distributable Cash”) will be allocated as to 50% each to the Company and 1186626, and 100% to the Company thereafter.

Under the terms of the Amended Agreement, the Capital Contribution will be $6,350,000 (the “Amended Contribution) to finance the completion of the Company’s 10,000 square foot facility, and the Project Distributable Cash has been amended as to 80% to 1186626 and 20% to the Company until the first year anniversary that 1186626’s Amended Contribution has been fully repaid, and 100% to the Company thereafter.

All other terms and conditions of the JV Agreement remain the same.

In consideration of the Amended Agreement, the Company agreed to terminate its joint venture agreement with 1186626 with respect to the Chase property located in British Columbia. Additionally, further to the Company’s press release dated April 22, 2019, the Company agreed to assign all of its right, title, interest in and to the Bud For You Inc. to 1186626.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President

RM@citationgrowth.com

1-877-438-5448 Extension 718

Paul Searle, Corporate Communications 1-877-438-5448 Extension 714 psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.